CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway (vol 90, pg 437, 2017) 期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2018, 卷号: 98, 页码: 925-926
作者:  Zheng, Guirong;  Shen, Zhichun;  Chen, Hongning;  Liu, Jian;  Jiang, Kai
收藏  |  浏览/下载:5/0  |  提交时间:2019/11/21
Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer 期刊论文
ACTA BIOMATERIALIA, 2018, 卷号: 76, 页码: 257-274
作者:  Lv, Tingting;  Li, Ziying;  Xu, Liang;  Zhang, Yingying;  Chen, Haijun
收藏  |  浏览/下载:11/0  |  提交时间:2019/11/21
Quantitative assessment of gene promoter methylation in non-small cell lung cancer using methylation-sensitive high-resolution melting 期刊论文
ONCOLOGY LETTERS, 2018, 卷号: 15, 页码: 7639-7648
作者:  Liu, Fangming;  Zhang, Honglian;  Lu, Shaohua;  Wu, Zhenhua;  Zhou, Lin
收藏  |  浏览/下载:11/0  |  提交时间:2019/11/21
Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway 期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2017, 卷号: 90, 页码: 437-445
作者:  Zheng, Guirong;  Shen, Zhichun;  Chen, Hongning;  Liu, Jian;  Jiang, Kai
收藏  |  浏览/下载:4/0  |  提交时间:2019/11/21
Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway 期刊论文
ONCOTARGET, 2017, 卷号: 8, 页码: 78351-78364
作者:  Shao, Jingwei;  Zheng, Guirong;  Chen, Hongning;  Liu, Jian;  Xu, Aixiao
收藏  |  浏览/下载:2/0  |  提交时间:2019/11/21


©版权所有 ©2017 CSpace - Powered by CSpace